Clinical trial
68Ga-HER2 Affibody PET/CT Imaging for HER2-Positive Cancer Patients
NCT05535621 is registered in ClinicalTrials.gov with Tongji Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- 68Ga-HER2 Affibody PET/CT Imaging for HER2-Positive Cancer Patients
- Lead sponsor
- Tongji Hospital
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- December 18, 2021
- Completion date
- December 30, 2025
- Enrollment
- 100 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
her2-positive cancer